Healthcare IT and generic drugs will core big, but medical devices, big pharma, and health insurers will take a hit, according to Wachovia survey.
Comprehensive healthcare reform will give a big lift to healthcare information technology and generic drugs, but it will hurt the medical device industry, according to a survey by Wachovia Capital Markets LLC.
The report, "The Changing Face of Heathcare," was compiled from data of a survey of more than 200 institutional investors, more than half in the northeastern United States.
About 71 percent of respondents thought Congress would pass some sort of healthcare reform in 2009, but less than 25 percent thought a single-payer system, similar to Canada's or Great Britain's, was likely.
Medical device company ViewRay announces a $17.4 million funding round, offering equity and Series D-...
The FDA slaps its highest-risk classification on Abbott Labs' FreeStyle InsuLinx blood glucose meter...
Weight-loss devices maker GI Dynamics tells investors today that the company may seek new funding as...
Medical device giant Medtronic announces CE Mark approval in the European Union and imminent...
Covidien restates its financial results for its fiscal 2nd quarter ahead of the spinout of its...